Section of Pediatric Gastroenterology, Hepatology and Nutrition, Pediatric Liver Transplant Center, Digestive Health Institute, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Adult and Child Center for Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
Pediatr Transplant. 2023 Sep;27(6):e14513. doi: 10.1111/petr.14513. Epub 2023 Mar 20.
COVID-19 vaccine is recommended for individuals ages ≥6 months; however, whether vaccination should be mandated for transplant candidates and living donors remains controversial. This study assessed COVID-19 policies at US pediatric solid organ transplant centers.
A 79-item survey was emailed between March and April 2022 to 200 UNOS Medical Directors detailing center COVID-19 vaccine policies for transplant candidates and living donors and use of grafts from COVID-19-positive deceased donors.
The response rate was 77% (154/200). For children aged 5-15 years, 23% (35/154 centers) have a COVID-19 vaccine mandate, 27% (42/154) anticipate implementing a future mandate, and 47% (72/154) have not considered or do not anticipate implementing a mandate. For children ≥16 years, 32% (50/154 centers) have a COVID-19 vaccine mandate, 25% (39/154) anticipate implementing a future mandate, and 40% (62/154) have not considered or do not anticipate implementing a mandate. The top two reasons for not implementing a COVID-19 vaccine mandate were concerns about penalizing a child for their parent's decision and worsening inequities in transplant. Of 85 kidney and liver living donor centers, 32% (27/85) require vaccination of donors. Twenty percent (31/154) of centers accept organs from COVID-19-positive deceased donors.
There is great variation among pediatric SOT centers in both the implementation and details of COVID-19 vaccine mandates for candidates and living donors. To guide more uniform policies, further data are needed on COVID-19 disease, vaccine efficacy, and use of grafts from donors positive for COVID-19 in the pediatric transplant population.
COVID-19 疫苗推荐给≥6 月龄的个体使用;然而,对于移植候选者和活体供者,疫苗接种是否应强制接种仍存在争议。本研究评估了美国儿科实体器官移植中心的 COVID-19 政策。
2022 年 3 月至 4 月期间,向 UNOS 医学主任发送了一份包含 79 个项目的调查,详细介绍了移植候选者和活体供者的中心 COVID-19 疫苗政策以及使用 COVID-19 阳性已故供者的移植物。
回复率为 77%(154/200)。对于 5-15 岁的儿童,23%(35/154 个中心)有 COVID-19 疫苗接种规定,27%(42/154)预计将实施未来的规定,47%(72/154)尚未考虑或不预计实施规定。对于≥16 岁的儿童,32%(50/154 个中心)有 COVID-19 疫苗接种规定,25%(39/154)预计将实施未来的规定,40%(62/154)尚未考虑或不预计实施规定。不实施 COVID-19 疫苗接种规定的前两个原因是担心因父母的决定而惩罚孩子,以及加剧移植中的不平等。在 85 个肾脏和肝脏活体供者中心中,32%(27/85)要求供者接种疫苗。20%(31/154)的中心接受 COVID-19 阳性已故供者的器官。
儿科 SOT 中心在候选者和活体供者的 COVID-19 疫苗接种规定的实施和细节方面存在很大差异。为了指导更统一的政策,还需要更多关于 COVID-19 疾病、疫苗效力以及在儿科移植人群中使用 COVID-19 阳性供者移植物的数据。